Exploring MSC-EV Attributes: Analytical Comparison of Tissue Sources & Production Platforms
To maximize therapeutic potential, MSC-EVs need established quality attributes. This webinar explores how analytical tools can assess the impact of production process choices and tissue source on quality attributes.
Watch Webinar
Introducing AgentV: A Scalable Solution for 10X Exosome Yield
Biological components in conditioned media are a consistent problem during downstream processing of exosomes. That's why RoosterBio developed AgentV-DSP, a solution designed to address filtration problems and increase particle yield up to 10-fold.
Watch Webinar
Preparing for the Clinic: Qualifying Analytical Methods
With the qualification of RoosterBio's lab to support GMP analytical testing, we want to share important considerations associated with migrating research use assays to fit-for-purpose analytical methods suitable for your transition to the clinic.
Watch Webinar
A Scalable Manufacturing Platform for the Purification of Stem Cell Derived Exosomes
RoosterBio and Cytiva joined forces to address challenges impacting clinical manufacturing and to characterize an exosome bioprocessing platform that delivers high EV yields and purity at clinically relevant scales.
Watch Webinar
Harnessing Synthetic Biology Tools to Engineer Smart Stem Cells for Musculoskeletal Repair
Tomas Gonzalez-Fernandez, PhD, Assistant Professor at Lehigh University, showcases his lab's progress and current strategies to increase CRISPR delivery and function in primary stem cells and progenitor cells.
Watch Webinar
Anti-fibrotic Effects of Extracellular Vesicles Produced by MSCs Maintained in Chemically Defined Medium
Guest speaker Dr. Stefania Bruno, Associate Professor of Medical and Biotechnology Laboratory Techniques at the University of Torino, Italy, showcases their lab’s recent work on extracellular vesicle production for tissue regeneration applications.
Watch Webinar
Advanced Technology for Vector-Based Therapies Highlighting Stem Cell-Derived Exosomes Manufacturing Process
In collaboration with Repligen Corporation, this webinar illustrates the benefits of integrated platforms for highly productive and cost-effective exosome manufacturing to meet increasing global demand.
Watch Webinar
Industry-University Partnership Accelerates MSC & EV Based Regenerative Medicine Applications
The University of Pittsburgh Vascular Bioengineering Laboratory aims to develop regenerative solutions to vascular-based diseases and studies abdominal aortic aneurysms, tissue-engineered vascular grafts, and chronic, non-healing wounds.
Watch Webinar
Redefining Extracellular Vesicle Production
RoosterBio’s collaboration with Univercells Technologies studied the feasibility of using the Scale-X™ Bioreactor System as a scalable platform for continuous and high-capacity manufacture of hMSC-exosomes in a reduced footprint.
Watch Webinar
From Manufacturing Through Characterization: Simplifying EV/Exosome Research & Development
EVs play a crucial role in cell communication. So what makes a good EV? Despite emerging and evolving guidelines such as MISEV, the answer is there is no “good EV” except for the EV that works for you!
Watch Webinar
Manufacturing Advances Unlock the Therapeutic Potential of MSC-Derived Exosomes
The tremendous promise of EVs has increased the number of researchers and developers exploring an array of therapeutic endpoints. Consistent, scalable manufacturing can bolster these programs toward clinical implementation.
Watch Webinar
Solving Challenges in Viral & Non-Viral Cell Engineering for Advanced Therapies
This webinar covers the impact of genetic modification technologies on primary cell engineering, key challenges in cell engineering, and a GMP-ready complete media platform.
Watch Webinar
Leverage GMP Working Cell Banks to Accelerate MSC & Exosome Therapies into the Clinic
A case study on how using off-the-shelf WCBs derived from established master cell banks can solidify the path to clinical implementation, saving critical time and resources.
Watch Webinar
EV Analytics: Know Your Process & Define Your Product
Size, heterogeneity, complex composition, and varying manufacturing processes make exosomes/extracellular vesicles a challenge for conventional analytical tools and strategies.
Watch Webinar
Translational Potential of hMSCs for Ocular Diseases
Alongside Dr. Ali Djalilian, we explore the therapeutic potential of MSCs for cornea and ocular surface diseases. We also discuss an allogeneic MSC source for the regenerative medicine supply chain, outlining how to plan for manufacturing scale-up during development.
Watch Webinar
The Role hMSCs Play in Bioengineering Solutions for Military Medicine
This client-led seminar explores developing hMSCs as living bioreactors for drug delivery, biomanufacturing platforms for complex biomolecules, 3D-printed orthopedic repair devices, and EVs for bioactive bandages.
Watch Webinar
Rapid Translation of a Cellular Therapeutic
In this webinar, we explore traditional challenges associated with the incorporation of human mesenchymal stem cells into cell therapies and the advances being made to improve clinical manufacturing readiness.
Watch Webinar
RoosterGEM™: Addressing Key Challenges in Efficient Gene Transfer to Primary Cells
RoosterGEM is the industry's first genetic engineering medium. In this webinar, you will learn how to improve transduction efficiency and reduce MOI, leading to lower vector and media costs.
Watch Webinar
Best Practices in RegenMed Product & Process Development
The goal of this webinar is to discuss the importance of building a strong cost model with a step-by-step MSC-based example and how your model can positively impact your product and process development.
Watch Webinar
Planning a Successful MSC Therapy for Rapid COVID Response
This webinar covers challenges and options available for cell therapy product developers in scaling production, including industry best practices that deliver rapid, safe, and cost-effective solutions to meet crisis demand.
Watch Webinar
Radically Simplifying Production of hMSC-EVs with Rapid Clinical Translation & Scale-up Potential
This presentation highlights strategies to radically simplify production of large quantities of EVs and the cGMP raw material requirements for rapid clinical translation.
Watch Webinar
Scalable Manufacturing of MSC-derived EVs
In this webinar, we discuss the manufacturing of EVs derived from mesenchymal stem cells, including the tissue source, cell state, and process parameters, and the importance of evaluating productivity in manufacturing processes.
Watch Webinar
Scaling Up MSC & EV Production in Bioreactors
The focus of this talk is the scale-up of MSC and EV production in bioreactors, including processes for successful commercialization of cell therapy products and quality EV production with the end goal in mind.
Watch Webinar